Learn why the next frontier in AI governance will involve real-time surveillance of algorithmic performance across institutions with guidance from Akshaya Bhagavathula and Michelle A. Williams.
- Virtual Reality Endpoints Improve Measurement Of Patients' Real-World Benefit
- Can't-Miss Advice On Selecting Your First AI-Enabled Vendor
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
ON-DEMAND WEBINARS
Watch as speakers explore the experiences of sites conducting digital and hybrid trials, discussing the critical benefits of a change management strategy and a unified digital trial platform.
In an era defined by rapid disruption and technological advancement, clinical operations leaders are under increasing pressure to enhance effectiveness while managing complex strategic trade-offs.
Castor joins experts from United Biosource (UBC) and Datavant to discuss all things real-world evidence, patient-centric technologies, and the role of tokenization in clinical research.
A panel of oncology experts shares how top life science companies are using a combination of DHTs, ePROs, clinical trial platforms, and more to ease oncology research and drastically reduce timelines.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1483104506 Document Digitization Concept]( "Discover Why Electronic Revisions Of ICFs Are Easier")
Discover Why Electronic Revisions Of ICFs Are EasierWhat does the ICF amendment or revision process look like within a digital platform and is this harder or easier than traditional paper-based approaches?
-
![eCOA-clinical-GettyImages-1331758896]( "Why The Everest Group Named Medable A Leader In eCOA")
Why The Everest Group Named Medable A Leader In eCOADiscover how this eCOA is leading the charge in accelerating study timelines, boosting patient engagement, and answering real sponsor needs.
-
![GettyImages-1391646149 technology]( "Providing Drug Supply Support In Complex Environments Through IRT")
Providing Drug Supply Support In Complex Environments Through IRTLearn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.
-
![teamwork collaboration data analysis-GettyImages-1473508651]( "Webinar Recap: How EDC Can Support Modern Clinical Trials")
Webinar Recap: How EDC Can Support Modern Clinical TrialsGain insights from our recent webinar focused on the critical role EDC systems play in supporting modern working practices and innovative trial designs, structured around four key themes.
-
![Hey, Clinical Trial Study Teams - Let’s Go eTMF Mobile]( "How DCTs Became The New Standard")
How DCTs Became The New StandardSee how the core features of DCTs have become the new default clinical trial practices for a variety of therapeutic areas, almost four years after the 2020 pandemic brought about their rise.
-
![electronic-medical-technology-GettyImages-1204743045]( "Broadening Eligibility Criteria Among Cancer Clinical Trials Patients")
Broadening Eligibility Criteria Among Cancer Clinical Trials PatientsThis study challenges the commonly applied exclusionary approach to clinical trials, particularly cancer trials, that underrepresent certain populations and limit the generalizability of research advancements.
-
![GettyImages-2117176337-diversity]( "Analyzing The FDA's Approach To Diversity In Clinical Trials")
Analyzing The FDA's Approach To Diversity In Clinical TrialsLearn how utilizing diverse data resources and collaborating with stakeholders enables sponsors to foster a culture of inclusivity, meet regulatory requirements and ultimately advance medical science.
-
![Medable ceo 2]( "Letter From The CEO: A New Era Of Drug Development Is Here")
Letter From The CEO: A New Era Of Drug Development Is HereThis letter from Medable CEO Michelle Longmire lays out why we created Studio, what it enables sponsors and CROs to do, and how it will help everyone bring more effective therapies to patients faster.
-
![Clinical Technology 2]( "4 Key eCOA Benefits To Speed Up Your Clinical Trial")
4 Key eCOA Benefits To Speed Up Your Clinical TrialAs the healthcare landscape moves towards a patient-centric approach, explore how sponsors and regulatory bodies look to eCOAs more and more for obtaining patient data.
-
![Medable]( "What Happened At ASCO 2024")
What Happened At ASCO 2024Discover our associates' insights on the key developments from ASCO 2024 that are set to shape the future of cancer care and patient outcomes.
